Open Access
Open access
Pharmaceutics, volume 15, issue 1, pages 226

Conformational Screening of Arbidol Solvates: Investigation via 2D NOESY

Publication typeJournal Article
Publication date2023-01-09
Journal: Pharmaceutics
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor5.4
ISSN19994923
Pharmaceutical Science
Abstract

Understanding of the nucleation process’s fundamental principles in saturated solutions is an urgent task. To do this task, it is necessary to control the formation of polymorphic forms of biologically active compounds. In certain cases, a compound can exist in a single polymorphic form, but have several solvates which can appear in different crystal forms, depending on the medium and conditions of formation, and show different pharmaceutical activity. In the present paper, we report on the analysis of Arbidol conformational preferences in two solvents of different polarities—deuterated chloroform and dimethyl sulfoxide—at 25 °C, using the 2D NOESY method. The Arbidol molecule has various solvate forms depending on the molecular conformation. The method based on the nuclear Overhauser effect spectroscopy was shown to be efficient in the analysis of complex heterocyclic compounds possessing conformation-dependent pseudo-polymorphism. It is one of the types of polymorphism observed in compounds forming crystal solvates. Combined use of NMR methods and X-ray data allowed determining of conformer populations of Arbidol in CDCl3 and DMSO-d6 which were found to be 8/92% and 37/63%, respectively. The preferred conformation in solution is the same that appears in stable crystal solvates of Arbidol.

Citations by journals

1
2
3
Journal of Molecular Liquids
Journal of Molecular Liquids, 3, 50%
Journal of Molecular Liquids
3 publications, 50%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 2, 33.33%
International Journal of Molecular Sciences
2 publications, 33.33%
Molecules
Molecules, 1, 16.67%
Molecules
1 publication, 16.67%
1
2
3

Citations by publishers

1
2
3
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 3, 50%
Multidisciplinary Digital Publishing Institute (MDPI)
3 publications, 50%
Elsevier
Elsevier, 3, 50%
Elsevier
3 publications, 50%
1
2
3
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Eventova V. A. et al. Conformational Screening of Arbidol Solvates: Investigation via 2D NOESY // Pharmaceutics. 2023. Vol. 15. No. 1. p. 226.
GOST all authors (up to 50) Copy
Eventova V. A., Belov K. V., Efimov S., Khodov I. A. Conformational Screening of Arbidol Solvates: Investigation via 2D NOESY // Pharmaceutics. 2023. Vol. 15. No. 1. p. 226.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3390/pharmaceutics15010226
UR - https://doi.org/10.3390%2Fpharmaceutics15010226
TI - Conformational Screening of Arbidol Solvates: Investigation via 2D NOESY
T2 - Pharmaceutics
AU - Eventova, Varvara A
AU - Belov, Konstantin V.
AU - Efimov, Sergey
AU - Khodov, Ilya A.
PY - 2023
DA - 2023/01/09 00:00:00
PB - Multidisciplinary Digital Publishing Institute (MDPI)
SP - 226
IS - 1
VL - 15
SN - 1999-4923
ER -
BibTex |
Cite this
BibTex Copy
@article{2023_Eventova,
author = {Varvara A Eventova and Konstantin V. Belov and Sergey Efimov and Ilya A. Khodov},
title = {Conformational Screening of Arbidol Solvates: Investigation via 2D NOESY},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
month = {jan},
url = {https://doi.org/10.3390%2Fpharmaceutics15010226},
number = {1},
pages = {226},
doi = {10.3390/pharmaceutics15010226}
}
MLA
Cite this
MLA Copy
Eventova, Varvara A., et al. “Conformational Screening of Arbidol Solvates: Investigation via 2D NOESY.” Pharmaceutics, vol. 15, no. 1, Jan. 2023, p. 226. https://doi.org/10.3390%2Fpharmaceutics15010226.
Found error?